Aurobindo Pharma Limited has informed the Exchange about
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges that its officials will attend a group investor meeting on June 25, 2025, from 5:00 PM to 6:00 PM IST. The meeting is being arranged by B&K Securities and will be held in-person in Hyderabad. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during the interaction. The schedule may change due to unforeseen circumstances on either side.
This is a routine disclosure about an investor engagement and is not expected to materially affect the stock price. It signals normal investor relations activity, with no new business or financial information being shared.